HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults [Phase 3]
Phase 3 trial evaluating tenofovir alafenamide added to a failing regimen, followed by a regimen including elvitegravir/cobicistat/emtricita…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial) [Phase 1]
The DALIA trial reports completion of a Phase 1 study evaluating vaccination with dendritic cells in HIV-1 infected patients receiving antir…
-
CLINICAL_TRIALS research · 2017-06-12Clinical Trial Update: Mathematical Modeling of the HIV Transmission Risk After Initiation of Antiretroviral Therapy in naïve HIV-infected
This clinical trial update discusses mathematical modeling of HIV transmission risk after starting antiretroviral therapy in ART-naïve HIV-1…
-
FDA approval · 2017-06-08FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)
FDA approved a supplemental application for Truvada (emtricitabine and tenofovir disoproxil fumarate) submitted by Gilead Sciences, Inc. The…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435 [Phase 1]
This Phase 1 study evaluated the relative bioavailability of tablet formulations of GSK2248761 in healthy adult subjects and has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-06-08FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's emtricitabine and tenofovir disoproxil fumarate as an original generic application for HIV-1 infection.
-
FDA approval · 2017-06-07FDA Approved: NORVIR — Original Application (AbbVie Inc.)
FDA approves NORVIR (ritonavir) from AbbVie as an original application for HIV infection; Ritonavir is an antiretroviral protease inhibitor …
-
FDA approval · 2017-06-07FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for NORVIR (ritonavir) by AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study) [NA]
The iTest clinical trial evaluated whether home HIV self-testing increases testing frequency among men who have sex with men. The study is c…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials
This entry reports a terminated cohort study of volunteers who participated in preventive HIV-1 vaccine trials, with sponsor information and…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: PENTA Fosamprenavir Study
The PENTA Fosamprenavir Study (NCT01077635) sponsored by ViiV Healthcare has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status
A clinical trial evaluating fractures in people living with HIV was completed, with analyses stratified by ART status.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults [Phase 2]
This update reports the completion of a Phase 2 trial evaluating GW640385 in combination with ritonavir and nucleoside reverse transcriptase…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir) [Phase 3]
Completed Phase 3 observational study evaluating a protease inhibitor–containing regimen in HIV patients with PI mutations selected during p…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: GW873140 In Combination With Kaletra In HIV Infected Subjects [Phase 2]
Phase 2 trial of GW873140 in combination with Kaletra for HIV infection was terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: GW873140 In Combination With Combivir In HIV Infected Subjects [Phase 2]
A Phase 2 trial evaluating GW873140 in combination with Combivir in HIV-infected subjects has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART [NA]
A completed clinical trial assessed whether L-Carnitine improves postprandial clearance of triglyceride-rich lipoproteins in HIV patients on…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults [Phase 2]
Phase 2 trial evaluating GW640385 boosted with ritonavir versus a ritonavir-boosted protease inhibitor in HIV-1 infected, protease inhibitor…
-
FDA approval · 2017-05-26FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Isentress (raltegravir) from Merck Sharp & Dohme LLC, resulting in changes to its labeling u…
-
FDA approval · 2017-05-26FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Isentress (raltegravir) submitted by Merck Sharp & Dohme LLC. The action updates the labelin…
-
FDA approval · 2017-05-26FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for ISENTRESS (raltegravir) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer [NA]
Clinical trial update reports results of a conditioning regimen using fludarabine and total-body irradiation followed by donor stem cell tra…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer [Phase 2]
Phase 2 trial update examining immune response after stem cell transplant in HIV-positive patients with hematologic cancer; the study status…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV [Phase 4]
This Phase 4 trial evaluated the safety, tolerability, and efficacy of Trizivir compared with Combivir plus Atazanavir in people with HIV; t…
-
FDA approval · 2017-05-23FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental NDA for Reyataz (atazanavir) from E.R. Squibb & Sons, L.L.C., authorizing changes requested in the supplemen…